Home Clinical Topics FDA approves new drug for type 2 diabetes

FDA approves new drug for type 2 diabetes

On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here